Meeting point at DIA Europe 2019 – 20 and 21 November – Lisbon Portugal
In march 2019, Universal Medica Group and EVERSANA have entered into a partnership to provide medical information and pharmacovigilance services throughout Europe, Asia and North, Central and South America. This strategic collaboration meets the evolving needs of Global clients. As a single, integrated service partner EVERSANA and Universal Medica Group deliver programs with the infrastructure, […]
BBac’s acquisition by UNIVERSAL MEDICA GROUP
Universal Medica Group (UMG) has reached a new stage in its development with the acquisition of BBac, a company specializing in pharmacovigilance and safety in the healthcare industry. This acquisition is part of the “Horizon 2020” strategic plan, which responds to the industry transformations and to needs of healthcare industry evolutions to promote the healthcare […]
DIA Europe 2018 – 17 & 19 Avril, Bazel Switzerland
Universal Medica your partner in medical communication will be present at this year’s DIA conference in Basel, Switzerland. We would like to share with you our vision of the evolution of Medical Affairs and listen to your current and future needs in this evolving environment. The future of drug safety management is changing and becoming a crucial […]
Interview – Emmanuelle B. : Pharmacovigilance Manager
Presentation I am a pharmacist (PharmD) and I have a University thesis in PharmacoEpidemiology (PhD). Afterwards, I worked during 15 years as a practitioner in the Regional Center of Pharmacovigilance (CRPV) of Toulouse before joining Universal Medica as Pharmacovigilance Manager (PV). During these 15 years, I carried out numerous appraisals for the ANSM, in particular […]
Webinar: Online reputation and crisis management on social media
What is an online reputation? An online reputation is the image a company, brand, service, organization or individual projects through their behavior and the content they communicate. All of these informations are transmitted through social media, online platforms, and other content published online. If positive, this information will help maintain a good reputation as well […]
Biomedical research reform: the Jardé law
The Jardé law, voted in March 2012, aims at giving a legal and statutory framework to clinical trials which involve people. Universal Medica summarizes for you the main points of the decree number 2017-884 of May 9th, 2017 which modifies certain arrangements. Creation of 3 new categories With the Jardé law, the “Biomedical Research (called […]
Interview – Medical Information project manager
Attracted by the Healthcare sector for a long time, after graduating with my doctorate in microbiology, I decided to enter the pharmaceutical industry and in particular to commit into concrete activities in connection with healthcare professionals and patients. This is how I joined Universal Medica as an attached scientist. In two years, I had a […]
What is medical information?
The primary role of medical information is to provide an answer to inquiries made by healthcare professionals and patients. The nature of their questions can be: Medical: Therapeutic Indications, Contraindications, Posology, Interactions with other medicinal products Pharmaceutical: dosage form, pharmacology, storage conditions … Crisis management-related: batch recall, stock shortage, etc. Find out more about the […]
Pharmacovigilance and Drug Safety in France
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem to enhance patient care and patient safety in relation to the use of medicines. Learn more about our pharmacovigilance services.
EudraVigilance enhanced functionalities
From November 22, 2017, EudraVigilance, the report database specialized on the unwanted effects of drugs use, is going to be updated. The EMA (European Medicines Agency) collects through this site the submitted statements by competent authorities and marketing authorization holders. EudraVigilance database is open to public since 2012 with the aim to further boost transparency […]
